+关注
草根鞋
暂无个人介绍
IP属地：浙江
17
关注
0
粉丝
5
主题
0
勋章
主贴
热门
草根鞋
2021-10-05
啊
抱歉，原内容已删除
草根鞋
2021-10-05
这篇文章不错，转发给大家看
抱歉，原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3567892660931642,"uuid":"3567892660931642","gmtCreate":1604798637589,"gmtModify":1604798637589,"name":"草根鞋","pinyin":"cgxcaogenxie","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":17,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":5,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.47%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"浙江","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":820491944,"gmtCreate":1633411240042,"gmtModify":1633411240042,"author":{"id":"3567892660931642","authorId":"3567892660931642","name":"草根鞋","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"啊","listText":"啊","text":"啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820491944","repostId":"2172996710","repostType":2,"isVote":1,"tweetType":1,"viewCount":541,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820491088,"gmtCreate":1633411226142,"gmtModify":1633411226142,"author":{"id":"3567892660931642","authorId":"3567892660931642","name":"草根鞋","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看","listText":"这篇文章不错，转发给大家看","text":"这篇文章不错，转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820491088","repostId":"2172996710","repostType":2,"isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":820491944,"gmtCreate":1633411240042,"gmtModify":1633411240042,"author":{"id":"3567892660931642","authorId":"3567892660931642","name":"草根鞋","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"啊","listText":"啊","text":"啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820491944","repostId":"2172996710","repostType":2,"repost":{"id":"2172996710","pubTimestamp":1633358099,"share":"https://www.laohu8.com/m/news/2172996710?lang=&edition=full","pubTime":"2021-10-04 22:34","market":"us","language":"zh","title":"默沙东新药的意义：疫苗之后，为何世界还需要“神药”","url":"https://stock-news.laohu8.com/highlight/detail?id=2172996710","media":"华尔街见闻","summary":"在家就可服用的抗新冠药丸可能会改变疫情的方向。","content":"<p>“完全接种疫苗的人仍然可能感染新冠，尤其是在疫苗效力减弱的情况下……我认为如果一个人被感染了新冠，就是被感染了，其是否接种疫苗并不重要。”</p>\n<p>这是福奇博士在接受CNBC采访、被问及新冠口服药molnupiravir是否会专门用于未接种疫苗的人群时所作的部分回答。</p>\n<p>自新冠疫情爆发以来，医生们一直希望有一种口服抗病毒药物可以防止最近感染的患者病情加重。</p>\n<p>近日，<a href=\"https://laohu8.com/S/MRK\">默沙东</a>（Merck）披露了与合作伙伴Ridgeback生物治疗公司共同开发的口服抗新冠病毒药丸molnupiravir的中期试验结果，能够降低一半的住院或死亡风险。</p>\n<p>默沙东公司称，该中期试验跟踪了775名患有轻度至中度新冠的成年人。试验结果显示，在新冠症状出现5天内，服用抗病毒口服药丸molnupiravir的患者中，仅7.3%的人在30天后住院或死亡，而服用安慰剂的患者中，这一比例为14.1%。</p>\n<p><b>针对疫苗接种率放缓及疫苗效力减弱的情形，这无疑是一个难得的好消息。</b></p>\n<p>到目前为止，新冠疫苗是抗击疫情的最好治疗工具。它们在很大程度上防止人们最终住院或死亡，尽管突破性感染病例正在上升。</p>\n<p><b>但与新冠疫苗不同的是，低收入国家的制造商不需要相关专业知识和专门的监督来生产这些药片。Molnupiravir可以很容易地在较贫穷的国家分发。</b></p>\n<p><b>而且实验还表明，该药物对不同变异病毒有效，不太可能产生病毒耐药性</b>：在大约40%的可进行测序的参与者中，该药物似乎也对gamma、delta和mu变异病毒有效。</p>\n<p>此外，<b>该药物可能有助于减少传播和突破性感染的严重程度。</b></p>\n<p><a href=\"https://laohu8.com/S/RY\">加拿大皇家银行</a>资本市场分析师Brian Abrahams上周五表示：</p>\n<blockquote>\n 可在门诊环境中使用的有效口服抗病毒药物可以降低与突破性感染相关的风险，并降低未接种疫苗者的死亡率，这可以开始使国家摆脱大流行并加速重新开放。\n</blockquote>\n<p>这意味着，如果molnupiravir等其他口服抗病毒药物获得授权或批准，它们很可能会改变疫情的进程，并使新冠病毒更接近于成为我们可以忍受的东西，而不是令人恐惧的东西。</p>","source":"wallstreetcn_api","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>默沙东新药的意义：疫苗之后，为何世界还需要“神药”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n默沙东新药的意义：疫苗之后，为何世界还需要“神药”\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-04 22:34 北京时间 <a href=https://wallstreetcn.com/articles/3641702><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>“完全接种疫苗的人仍然可能感染新冠，尤其是在疫苗效力减弱的情况下……我认为如果一个人被感染了新冠，就是被感染了，其是否接种疫苗并不重要。”\n这是福奇博士在接受CNBC采访、被问及新冠口服药molnupiravir是否会专门用于未接种疫苗的人群时所作的部分回答。\n自新冠疫情爆发以来，医生们一直希望有一种口服抗病毒药物可以防止最近感染的患者病情加重。\n近日，默沙东（Merck）披露了与合作伙伴...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3641702\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/33b134fbb35ab824bb17aba1c0832bb3","relate_stocks":{"MRK":"默沙东"},"source_url":"https://wallstreetcn.com/articles/3641702","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172996710","content_text":"“完全接种疫苗的人仍然可能感染新冠，尤其是在疫苗效力减弱的情况下……我认为如果一个人被感染了新冠，就是被感染了，其是否接种疫苗并不重要。”\n这是福奇博士在接受CNBC采访、被问及新冠口服药molnupiravir是否会专门用于未接种疫苗的人群时所作的部分回答。\n自新冠疫情爆发以来，医生们一直希望有一种口服抗病毒药物可以防止最近感染的患者病情加重。\n近日，默沙东（Merck）披露了与合作伙伴Ridgeback生物治疗公司共同开发的口服抗新冠病毒药丸molnupiravir的中期试验结果，能够降低一半的住院或死亡风险。\n默沙东公司称，该中期试验跟踪了775名患有轻度至中度新冠的成年人。试验结果显示，在新冠症状出现5天内，服用抗病毒口服药丸molnupiravir的患者中，仅7.3%的人在30天后住院或死亡，而服用安慰剂的患者中，这一比例为14.1%。\n针对疫苗接种率放缓及疫苗效力减弱的情形，这无疑是一个难得的好消息。\n到目前为止，新冠疫苗是抗击疫情的最好治疗工具。它们在很大程度上防止人们最终住院或死亡，尽管突破性感染病例正在上升。\n但与新冠疫苗不同的是，低收入国家的制造商不需要相关专业知识和专门的监督来生产这些药片。Molnupiravir可以很容易地在较贫穷的国家分发。\n而且实验还表明，该药物对不同变异病毒有效，不太可能产生病毒耐药性：在大约40%的可进行测序的参与者中，该药物似乎也对gamma、delta和mu变异病毒有效。\n此外，该药物可能有助于减少传播和突破性感染的严重程度。\n加拿大皇家银行资本市场分析师Brian Abrahams上周五表示：\n\n 可在门诊环境中使用的有效口服抗病毒药物可以降低与突破性感染相关的风险，并降低未接种疫苗者的死亡率，这可以开始使国家摆脱大流行并加速重新开放。\n\n这意味着，如果molnupiravir等其他口服抗病毒药物获得授权或批准，它们很可能会改变疫情的进程，并使新冠病毒更接近于成为我们可以忍受的东西，而不是令人恐惧的东西。","news_type":1},"isVote":1,"tweetType":1,"viewCount":541,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820491088,"gmtCreate":1633411226142,"gmtModify":1633411226142,"author":{"id":"3567892660931642","authorId":"3567892660931642","name":"草根鞋","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看","listText":"这篇文章不错，转发给大家看","text":"这篇文章不错，转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820491088","repostId":"2172996710","repostType":2,"isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
